The brain's waste-clearing system significantly declines in function with repeated head impacts, according to a new study of ...
The novel B cell-targeting therapy ianalumab demonstrated improvement over placebo in key Sjögren’s disease parameters, ...
Passive organic upconversion and nanophotonic enhancements convert weak infrared light into visible images, enabling passive ...
Forte Group announces its planned corporate transformation to Vanta Holdings Inc. (VANTA), marking a significant milestone in the Company's evolution into a next-generation wellness ...
As the first and only PD-L1 immune checkpoint inhibitor approved for aCSCC, UNLOXCYT is an evolution in checkpoint inhibition, offering a balance of durable clinical ...
The post came after Nvidia saw its shares fall 3 per cent in Tuesday’s trade after a report in San Francisco-based tech ...